Current status of universal newborn hearing screening

Current Opinion in Otolaryngology and Head and Neck Surgery

Volumn 8, Issue 5, 2000, Pages 404-408

  Fujikawa, Sharon ^a,b   Yoshinaga Itano, Christine ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUDIOLOGY; BRAIN STEM RESPONSE; COCHLEAR NERVE; CYTOMEGALOVIRUS; DIAGNOSTIC PROCEDURE; EARLY DIAGNOSIS; HEALTH PROGRAM; HUMAN; NEUROPATHY; NEWBORN; NEWBORN SCREENING; OTOACOUSTIC EMISSION; OTORHINOLARYNGOLOGY; PERCEPTION DEAFNESS; PREVALENCE; PRIMARY HEALTH CARE; PRIORITY JOURNAL; REVIEW; SCREENING TEST; VALIDATION PROCESS;

EID: 0034453766     PISSN: 10689508     EISSN: None     Source Type: Journal    
DOI: 10.1097/00020840-200010000-00009     Document Type: Review

References (42)

1. Language development of early- and later-identified children with hearing loss
2. Benefits of early intervention for children with hearing loss
3. The epidemiology of childhood hearing impairment: Factors relevant to planning of services
4. Newborn and infant hearing loss: Detection and intervention, American Academy of Pediatrics, Task Force on Newborn and Infant Hearing, 1998-1999
5. Detection of hearing loss in children
6. Hearing screening: Aspects of epidemiology and identification of hearing impaired children
7. Universal newborn hearing screening: Should we leap before we look?
8. Identifying hearing loss: Parents' needs
9. The parents' view on hearing screening in newborns: Feelings, thought and opinions on otoacoustio emissions screening
10. The Marion Downs National Center for lnfant Hearing
11. Hear early
12. Controlling the quality of universal neonatal hearing screens
13. Challenges to universal newborn hearing screening in a South Carolina Regional Medical Center
14. Controlled trial of universal neonate screening for early identification of permanent childhood hearing impairment
15. Newborn auditory screening with ALGO-1 vs. conventional auditory brainstem response
16. Automated and conventional ABR screening techniques in high-risk infants
17. Automated auditory brainstem response testing for universal newborn hearing screening
18. The Rhode island Hearing Assessment Program: Experience with statewide hearing screening (1993-1996)
19. The use of transient evoked otoaooustio emissions in neonatal hearing screening programs
20. New approaches to the evaluation of the auditory system and a current analysis of otoaooustio emissions
21. Auditory screening in neonates by means of transient evoked otoaooustio emissions: A report of 2842 recordings
22. Transient evoked otoaooustio emissions (TEOAEs) in new-borns: Normative data
23. Otoacoustic emission-based hearing screening of a Greek NICU population
24. Otoacoustic emission criteria for neonatal hearing screening
25. A TEOAE screening protocol based on linear click stimuli: Performance and scoring criteria
26. Distortion-product otoaooustio emissions (DPEs) in neonates: Frequency ratio (F2/F1) and stimulus level differences (L1-L2)
27. Maturation of transient evoked otoacoustic emissions
28. Maturation of click evoked otoacoustic emissions in the first few days of life
29. The postnatal growth period of the click evoked otoacoustic emission in healthy newborns
30. Maturation of distortion product otoacoustic emissions
31. Neonatal and hearing screening with otoseopy, auditory brainstem response, and otoaeoustie emissions
32. Otological evaluation of newborns who failed otoaeoustie emission screening
33. Hearing screening in the newborn intensive care nursery: Comparison of methods
34. Confirmation of deafness in infancy
35. Age of suspicion, identification and intervention for infants and young children with hearing loss: A national study
36. Potential pitfalls of initiating a newborn hearing screening program
37. Relative and attributable risks for moderate to profound bilateral sensorineural hearing impairment associated with lower birth weight in children 3 to 10 years old
38. Neonatal screening for hearing disorders in infants at risk: Incidence, risk factors, and follow-up
39. Congenital and perinatal eytomegalovirus infections
40. Newborn hearing screening: Will children with hearing loss caused by congenital cytomegalovirus infection be missed?
41. Neonatal screening for congenital cytomegalovirus infections
42. Auditory neuropathy